Table 3.
Summary of follicular lymphoma detected in association with Warthin tumor
Study | Year | Age | Sex | Location | Pattern | Grade | Stage | Other organs involved at diagnosis/treatment | Follow up |
---|---|---|---|---|---|---|---|---|---|
Colby et al. [17] | 1979 | NA | NA | Parotid | F | 1 | NA | Regional LNs | NA |
Seifert et al. [2] | 1980 | 83 | M | Parotid | NA | NA | NA | Regional LNs | NA |
Miller et al. [16] | 1982 | 49 | M | Angle of mandible | NA | 1 | IA | None | 3 months later surgical excision of regional LNs had NHL |
Banik et al. [8] | 1984 | 75 | M | Left parotid | D | 2 | NA | None | NA |
76 | M | Right parotid | F + D | 2 | IIIA | Generalized LNs (CT: chlorambucil and prednisone) | NHL in neck LNs 1 year later | ||
Hall et al. [15] | 1985 | 64 | M | Right parotid | F + D | 2 | IA | None | Generalized NHL 7 months later |
Griesser et al. [14] | 1986 | 64 | F | Palate | F | 2 | NA | NA | NA |
Medeiros et al. [13] | 1990 | 71 | M | Left parotid | F + D | 2 | IIIA | Periaortic LNs (CT: V-16; adriamycin, cyclophosphamide, vincristine, prednisone, bleomycin) | NED 48 months later |
Giardini et al. [12] | 1990 | 57 | M | Right and left parotid | F | 1 | IIA | Regional LNs (CT: endoxan, vincristine, predinisone) | NED 3 years later |
Shikhani et al. [10] | 1993 | 56 | M | Right Parotid | NA | NA | IA | None (RT: 4500 rads) | Axillary LN recurrence 4 years 4 months later. Died of generalized NHL 7 years after initial diagnosis |
Park et al. [11] | 2000 | 68 | F | Right peri-parotid LN | F | 1 | IA | None (RT: unknown dose) | 4.5 years later inguinal LN NHL, complete clinical remission after combination CT |
55 | M | Right parotid | F | 1 | IIA | Axillary LN | NA | ||
Romero et al. [18] | 2016 | 82 | F | Right Parotid | F | Low | IV | None (CT: 4 cycles of Rituximab) | Improved thrombocytopenia |
Present case | 2018 | 69 | M | Right neck LN | F | 1–2 | IV | Generalized LNs, Spine and Pelvic bone (No CT or RT given) | Recent study |
Diagnosis translated into terminology according to World Health Organization Classification of Tumors when possible
F follicular; D diffuse; LN lymph node; NHL non-Hodgkin lymphoma; NA not available; NED no evidence of disease; CT chemotherapy; RT radiation therapy